Appendix H: BW Agents: Characteristics

Disease

Transmit Man to Man

Infective Dose (Aerosol)

Incubation Period

Duration of Illness

Lethality

Persistence of Organism

Vaccine Efficacy(aerosol exposure)

Inhalation anthrax

No

8,000-50,000 spores

1-6 days

3-5 days (usually fatal if untreated)

High

Very stable - spores remain viable for > 40 years in soil

2 dose efficacy against 200-500 LD50 in monkeys

Brucellosis

No

10 -100 organisms

5-60 days (usually 1-2 months)

Weeks to months

<5% untreated

Very stable

No vaccine

Cholera

Rare

10-500 organisms

4 hours - 5 days (usually 2-3 days)

> 1 week

Low with treatment, high without

Unstable in aerosols & fresh water; stable in salt water

No data on aerosol

Glanders

Low

Assumed low

10-14 days via aerosol

Death in 7-10 days in septicemic form

> 50%

Very stable

No vaccine

Pneumonic Plague

High

100-500 organisms

2-3 days

1-6 days(usually fatal)

High unless treated within 12-24 hours

For up to 1 year in soil; 270 days in live tissue

3 doses not protective against 118 LD50 in monkeys

Tularemia

No

10-50 organisms

2-10 days (average 3-5)

> 2 weeks

Moderate if untreated

For months in moist soil or other media

80% protection against

1-10 LD50

Q Fever

Rare

1-10 organisms

10-40 days

2-14 days

Very low

For months on wood and sand

94% protection against 3,500 LD50 in guinea pigs

Smallpox

High

Assumed low (10-100 organisms)

7-17 days (average 12)

4 weeks

High to moderate

Very stable

Vaccine protects against large doses in primates

Venezuelan Equine Encephalitis

Low

10-100 organisms

2-6 days

Days to weeks

Low

Relatively unstable

TC 83 protects against 30-500 LD50 in hamsters

Viral Hemorrhagic Fevers

Moderate

1-10 organisms

4-21 days

Death between 7-16 days

High for Zaire strain, moderate with Sudan

Relatively unstable

No vaccine

Botulism

No

0.001 m g/kg is LD50 for type A

1-5 days

Death in 24-72 hours; lasts months if not lethal

High without respiratory support

For weeks in nonmoving water and food

3 dose efficacy 100% against 25-250 LD50 in primates

Staph Enterotoxin B

No

0.03 m g/person incapacitation

3-12 hours after inhalation

Hours

< 1%

Resistant to freezing

No vaccine

Ricin

No

3-5 m g/kg is LD50 in mice

18-24 hours

Days - death within 10-12 days for ingestion

High

Stable

No vaccine

T-2 Mycotoxins

No

Moderate

2-4 hours

Days to months

Moderate

For years at room temperature

No vaccine

 


Nuclear

Nuclear

Biological

Biological

Chemical

Chemical

North Anna Power Station

Surry Power Station

UVA Nuclear Reactor Facility
Decommissioned in 1998

FEMA Fact Sheet:
Nuclear Power Plant Emergency

 

Introduction

Medical Management

History of Biological Warfare and Current Threat

Medical Aspects of the Biological Threat

Bacterial Agents
 
Anthrax
  
Brucellosis
   Cholera
   Glanders
   Plague
   Tularemia
   Q Fever

Viruses
    Smallpox
    Venezuelan Equine Encephalitis
    Viral Hemorrhagic Fevers

Biological Toxins
  Botulinum
   Staphylococcal Enterotoxin B
   Ricin
   T-2 Mycotoxins

Personal Protection

Decontamination

Appendix A:
Glossary of Medical Terms

Appendix B:
Patient and Precaution Levels

Appendix C
Comparative Lethality: Toxins/Chemicals

Appendix D:
Aerosol Toxicity: Toxins

Appendix E:
Differential Diagnosis: Toxins/Nerve Agent

Appendix F:
Specimens for Lab Diagnosis

Appendix G:
BW Agents: Lab Identification

Appendix H:
BW Agents: Characteristics

Appendix I:
BW Agents: Vaccines, Therapeutics and Prophylactics

Appendix J:
Medical Sample Collection for Biological Threat Agents

Introduction

Nerve Agents

Mustard Agents

Hydrogen Cyanide

Tear Gases

Arsines

Psychotomimetic Agents

Toxins

Potential CW Agents